Other news to note
Pharmaessentia Corp., of Taiwan, and Kinex Pharmaceuticals Inc., of Buffalo, N.Y., said they executed a new licensing agreement granting Pharmaessentia exclusive development and commercial rights to Oraxol and Oratecan in Taiwan and Singapore. Kinex will receive an undisclosed up-front payment, milestones and royalties, and Pharmaessentia also agreed to conduct clinical studies in Taiwan to contribute to the global registration programs for the drugs.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter